Literature DB >> 23182672

Crizotinib-induced acute hepatitis: first case with relapse after reintroduction with reduced dose.

Marie-Pierre Ripault1, Véronique Pinzani, Véronique Fayolle, Georges-Philippe Pageaux, Dominique Larrey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23182672     DOI： 10.1016/j.clinre.2012.10.003

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN： 2210-7401            Impact factor:   2.947


× No keyword cloud information.
  7 in total

1.  Successful oral desensitization with crizotinib after crizotinib-induced hepatitis in an anaplastic lymphoma kinase-rearranged non-small-cell lung cancer patient: A case report.

Authors:  Yuto Yasuda; Yasuyo Nishikawa; Yuichi Sakamori; Makoto Terao; Kentaro Hashimoto; Tomoko Funazo; Takashi Nomizo; Takahiro Tsuji; Hironori Yoshida; Hiroki Nagai; Hiroaki Ozasa; Toyohiro Hirai; Young Hak Kim
Journal:  Mol Clin Oncol       Date:  2017-06-29

2.  Crizotinib-induced toxicity in an experimental rat model.

Authors:  Ozge Gumusay; Guldal Esendagli-Yilmaz; Aytug Uner; Bulent Cetin; Suleyman Buyukberber; Mustafa Benekli; Mustafa N Ilhan; Ugur Coskun; Ozlem Gulbahar; Ahmet Ozet
Journal:  Wien Klin Wochenschr       Date:  2016-03-14       Impact factor: 1.704

Review 3.  Hepatitis C virus reactivation in cancer patients in the era of targeted therapies.

Authors:  Ozan Yazici; Mehmet Ali Nahit Sendur; Sercan Aksoy
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

Review 4.  RUCAM in Drug and Herb Induced Liver Injury: The Update.

Authors:  Gaby Danan; Rolf Teschke
Journal:  Int J Mol Sci       Date:  2015-12-24       Impact factor: 5.923

5.  Resolution of Crizotinib-Associated Fulminant Hepatitis following Cessation of Treatment.

Authors:  Gregory W Charville; Sukhmani K Padda; Richard K Sibley; Ajithkumar Puthillath; Paul Y Kwo
Journal:  Case Reports Hepatol       Date:  2018-08-05

6.  Successful Desensitization with Crizotinib after Crizotinib-induced Liver Injury in ROS1-rearranged Lung Adenocarcinoma.

Authors:  Takayo Ota; Noriyuki Masuda; Kaoru Matsui; Takao Yamada; Noriko Tanaka; Shunsuke Fujimoto; Masahiro Fukuoka
Journal:  Intern Med       Date:  2019-06-07       Impact factor: 1.271

7.  Crizotinib-Induced Fulminant Hepatic Failure: A Rare Adverse Event.

Authors:  Narayan Adhikari; Pavnesh Kumar; Bhanu P Venkatesulu; Rambha Pandey; Kunhiparambath P Haresh; Subhash Gupta; Daya N Sharma; Goura K Rath
Journal:  J Glob Oncol       Date:  2016-12-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.